Pilot study of bevacizumab in combination with docetaxel and cyclophosphamide as adjuvant treatment for patients with early stage HER-2 negative breast cancer, including analysis of candidate circulating markers of cardiac toxicity: ICORG 08-10 trial
一项针对早期 HER-2 阴性乳腺癌患者的辅助治疗方案的贝伐珠单抗联合多西他赛和环磷酰胺的试点研究,包括对心脏毒性候选循环标志物的分析:ICORG 08-10 试验
期刊:Therapeutic Advances in Medical Oncology
影响因子:4.2
doi:10.1177/1758835919864236
Gullo, Giuseppe; J Eustace, Alex; Canonici, Alexandra; M Collins, Denis; Kennedy, Michael J; Grogan, Liam; Breathhnach, Oscar; McCaffrey, John; Keane, Maccon; Martin, Michael J; Gupta, Rajnish; Leonard, Gregory; O'Connor, Miriam; Calvert, Paula M; Donnellan, Paul; Walshe, Janice; McDermott, Enda; Scott, Kathleen; Hernando, Andres; Parker, Imelda; W Murray, David; C O'Farrell, Alice; Maratha, Ashwini; Dicker, Patrick; Rafferty, Mairin; Murphy, Verena; O'Donovan, Norma; M Gallagher, William; Ky, Bonnie; Tryfonopoulos, Dimitrios; Moulton, Brian; T Byrne, Annette; Crown, John